Health
CREB1: A Potential Target for Treating Pancreatic Cancer – Technology Networks
Preclinical research using cell lines, genetic mouse models and human pancreatic tumor tissue samples has identified the transcription factor CREB1 as a potential…
Preclinical experiments using cell lines, genetic mouse models, and human pancreatic tumor tissue identified the transcription factor CREB1 (for cyclic AMP-responsive element binding protein 1) as a potential therapeutic target for the treatment of pancreatic cancer, according to results presented during Week 1 of the virtual AACR Annual Meeting 2021, held April 10-15. This study is being simultaneously published in Cancer Discovery, a journal of the American Association for Cancer Research.
Pancreatic…
-
Noosa News14 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News16 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General20 hours agoOne person dead after house fire in Melbourne’s south-east
-
Noosa News17 hours agoFarmers cut costs using molasses, manure to brew fermented fertiliser